Effect of Dietary Sodium Intake on Vascular Endothelium
NCT01550315 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 27
Last updated 2022-01-05
Summary
The investigators will test the hypothesis that markers of vascular endothelial dysfunction will be exaggerated acutely with an extreme high sodium diet compared to an extreme low-sodium diet. The investigators will compare patients with postural orthostatic tachycardia (POTS) to healthy control subjects.
Conditions
- Postural Tachycardia Syndrome (POTS)
Interventions
- PROCEDURE
-
Pulsitile Arterial Tonometry (PAT) Protocol
* A blood pressure cuff will be placed on one upper arm (study arm; non-dominant), while the contralateral arm will serve as a control (control arm). * RH-PAT probes will be placed on one finger (finger II, III, or IV) of each hand (same finger on both hands). The fingers on either side of the one with the probe will be separated using soft sponge rings. * Continuous recording of pulsatile blood volume responses from both hands will be initiated. * After a 10-min equilibration period, the blood pressure cuff on the study arm will be inflated to 60 mm Hg above systolic pressure for 5 min. The cuff will then be deflated to induce reactive hyperemia, PAT recording will be stopped.
- DEVICE
-
Calf Blood Flow in Reactive Hyperemia (CBF-RH)
Calf blood flow (CBF) will be determined using venous occlusion plethysmography and calibrated mercury strain-gauges during reactive hyperemia after a 5 min of ischemia of the distal limb. Strain-gauges will be applied to the widest part of the non-dominant calf (\~10 cm below patella). Participants will remain quietly supine for 10 min with legs elevated on foam pads above the right atrium to achieve stable baseline measurements of CBF. The venous occlusion cuff is inflated for 4 seconds at 8 seconds intervals, while monitoring the change in resistance in the system, pressure inside the measuring cuff, and 5-10 determinations are performed
- DEVICE
-
Evaluation of Forearm-Mediated Dilation
The arm will be kept extended and immobilized at heart level. Brachial artery diameter will be measured using a high resolution ultrasonography using a linear array probe with a 5 to 17 MHz frequency range. The brachial artery will be imaged in longitudinal sections, 5-10 cm proximal to placement of an occlusion cuff in the dominant forearm just below the antecubital fossa. The probe will be held with a stereotaxic holder with micrometer movement capabilities.
Sponsors & Collaborators
-
National Institutes of Health (NIH)
collaborator NIH -
National Heart, Lung, and Blood Institute (NHLBI)
collaborator NIH -
Vanderbilt University Medical Center
lead OTHER
Principal Investigators
-
Satish R Raj, MD MSCI · Vanderbilt University
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2012-04-30
- Primary Completion
- 2020-12-31
- Completion
- 2021-09-30
Countries
- United States
Study Locations
More Related Trials
-
Renal Salt Handling in Postural Tachycardia Syndrome Following Dietary Dopa Administration
NCT01064739 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Aldosterone & Sodium Regulation in Postural Tachycardia Syndrome - Screening
NCT01783288 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Adverse Neurogenic Actions of Dietary Salt
NCT02881515 ·Status: COMPLETED ·Phase: NA
-
Vascular Effects of Dietary Salt in Humans With Salt-Resistant Blood Pressure
NCT03424993 ·Status: COMPLETED ·Phase: PHASE4
-
Dopamine in Orthostatic Tolerance
NCT00748228 ·Status: TERMINATED ·Phase: NA
-
The Potassium Supplementation Study
NCT05887622 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Sodium Lowering Vascular Effects Trial
NCT05388032 ·Status: RECRUITING ·Phase: NA
-
Peripheral Dopamine in Postural Tachycardia Syndrome
NCT00685919 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Dietary Sodium Intake in Acute Heart Failure
NCT03722069 ·Status: COMPLETED ·Phase: NA
-
Dietary Salt Intake and Vascular Function
NCT00590512 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Mechanisms of Refractory Hypertension (High and Low Salt Diet)
NCT02357017 ·Status: WITHDRAWN ·Phase: NA
-
Effects of Acute Dietary Sodium on Cerebrovascular Reactivity and Blood Pressure Reactivity
NCT03564262 ·Status: COMPLETED ·Phase: NA
-
Natriuretic Peptide System as Therapy in Human Preclinical Left Ventricle Dysfunction
NCT00387621 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Treatment of Supine Hypertension in Autonomic Failure
NCT00223717 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy of Dietary Sodium Restriction of Improving Vascular Endothelial Function in Middle Aged and Older Adults
NCT01566084 ·Status: COMPLETED ·Phase: NA
-
Dietary Nitrates and Vascular Function in Patients With Peripheral Artery Disease
NCT01983826 ·Status: COMPLETED ·Phase: NA
-
Mechanisms Underlying the Protective Vascular Effects of Dietary Potassium in Humans
NCT04101188 ·Status: RECRUITING ·Phase: NA
-
Intervention for Monitoring of Salt Intake in Hypertensive Patients
NCT05397054 ·Status: UNKNOWN ·Phase: NA
-
The Effect of Sodium Reduction on Blood Pressure and Physical Function in Older Adults
NCT04074941 ·Status: COMPLETED ·Phase: NA
-
Blood Pressure and Diurnal Variation in Sodium, Potassium, and Water Excretion
NCT00005204 ·Status: COMPLETED
-
Pre-clinical Cardiac Dysfunction Among Asymptomatic Hypertensive Patients
NCT00689819 ·Status: COMPLETED ·Phase: NA
-
Renal Metabolism in Salt-sensitive Human Blood Pressure
NCT05369416 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Nocturnal Hypertension and Non-Dipping Blood Pressure
NCT03128177 ·Status: COMPLETED ·Phase: NA
-
Potassium-Magnesium Citrate as a Blood Pressure Lowering Agent in Hypertensive Patients
NCT01074918 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Evaluating the Effects of Nitroglycerin on Heart Function and Urinary Output in Patients With Acute Heart Failure
NCT06682260 ·Status: COMPLETED ·Phase: PHASE4